| __timestamp | BioMarin Pharmaceutical Inc. | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 74244000000 |
| Thursday, January 1, 2015 | 737887000 | 91739000000 |
| Friday, January 1, 2016 | 907234000 | 94597000000 |
| Sunday, January 1, 2017 | 1071860000 | 94064000000 |
| Monday, January 1, 2018 | 1175948000 | 94214000000 |
| Tuesday, January 1, 2019 | 1344582000 | 101933000000 |
| Wednesday, January 1, 2020 | 1336183000 | 106014000000 |
| Friday, January 1, 2021 | 1375760000 | 117142000000 |
| Saturday, January 1, 2022 | 1612370000 | 148506000000 |
| Sunday, January 1, 2023 | 1842161000 | 196496000000 |
| Monday, January 1, 2024 | 2273680000 | 245881000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding financial performance is crucial. This analysis compares the gross profit trends of Novo Nordisk A/S and BioMarin Pharmaceutical Inc. from 2014 to 2023. Novo Nordisk, a leader in diabetes care, has shown a remarkable growth trajectory, with its gross profit increasing by approximately 165% over the decade. In contrast, BioMarin, known for its focus on rare diseases, has seen a more modest growth of around 196% in the same period.
By 2023, Novo Nordisk's gross profit was nearly 100 times that of BioMarin, highlighting its dominant market position. This disparity underscores the varying scales and market strategies of these two pharmaceutical giants. As the industry continues to innovate, monitoring such financial metrics will be key to understanding future market dynamics.
Key Insights on Gross Profit: Novo Nordisk A/S vs Biogen Inc.
Novo Nordisk A/S and Exelixis, Inc.: A Detailed Gross Profit Analysis
Novo Nordisk A/S vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Novo Nordisk A/S and Evotec SE
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or BioMarin Pharmaceutical Inc.
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Genmab A/S and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Incyte Corporation and BioMarin Pharmaceutical Inc. Trends
BioMarin Pharmaceutical Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis